首页|基于FDA不良事件报告系统数据库的阿柏西普眼内注射溶液不良反应信号挖掘

基于FDA不良事件报告系统数据库的阿柏西普眼内注射溶液不良反应信号挖掘

扫码查看
目的 基于FDA不良事件报告系统(FAERS)数据库挖掘阿柏西普眼内注射溶液ADR信号,为临床安全用药提供参考.方法 采用报告比值比法(ROR)、比例报告比值比(PRR)及贝叶斯置信传播神经网络(BCPNN)法,对2004年第1季度至2022年第3季度阿柏西普眼内注射溶液相关药品不良事件(ADE)进行数据挖掘.结果 共筛选得到ADE为10 500 309条,筛选去重后阿柏西普眼内注射溶液的ADE报告共15 658份.其中共挖掘到ADR信号429个,主要集中于眼器官疾病、全身性疾病及给药部位各种反应、各类损伤中毒及操作并发症、各类神经系统疾病、各种手术及医疗操作、感染及侵染类疾病、耳及迷路类疾病.信号强度排名前5位的分别是非感染性眼内炎、眼内炎、玻璃体切割术、玻璃体炎和一过性失明;同时也发现说明书上未报道的如痴呆、听觉减退、突发性听力丧失等可疑ADR信号.结论 应重视阿柏西普眼内注射溶液药品说明书及文献中报道的ADR,加强药学监护.对于本研究发现的未报道的可疑ADR信号,应开展进一步的研究.此外,阿柏西普眼内注射溶液对眼科医师操作技能的熟练程度有一定要求,需做好相关培训.
Mining of adverse reaction signal of aflibercept intraocular injection based on FDA adverse event reporting system database
Objective To explore the extraction adverse drug reaction(ADR)signals of aflibercept intravenous injection,using the FDA adverse event reporting system(FAERS)database,and provide a reference for the safe and rational medication.Methods The reporting odds ratio(ROR),proportional reporting ratio(PRR)and Bayesian confidence propagation neural network(BCPNN)were used to detect the adverse drug events(ADEs)of aflibercept intravenous injection from the first quarter of 2004 to the third quarter of 2020 in the FAERS.Results Among 10 500 309 ADE reports retrieved related to aflibercept in-travenous injection,including 15 658 ADE reports after filter and duplication.A total of 429 ADR signals were detected,in-cluding ocular organ diseases,systemic diseases and reactions at the administration site,various injuries,poisoning and opera-tional complications,various neurological diseases,various surgical and medical procedures,infectious diseases,ear and lab-yrinth diseases.The top 5 ADR signals by frequency were noninfectious endophthalmitis,endophthalmitis,vitrectomy,vitre-ous inflammation,and transient blindness.Meanwhile,suspicious ADR signals such as dementia,hypoacusis,and sudden hearing loss,which not been mentioned in the drug labels,were also detected.Conclusion This study suggests that we should pay more attention to the ADR of aflibercept intravenous injection mentioned in the drug instructions and literature,and strengthen pharmaceutical care.Further research should be conducted on the unreported suspicious ADR signals discovered in this study.In addition,the use of aflibercept intravenous injection requires high operation proficiency of ophthalmologist,and relevant training should be done.

intravitreal afliberceptFDA adverse event reporting system databaseadverse drug eventsadverse reaction signaldata mining

张雪、谈仪炯、熊学惠、李琴、席宇飞

展开 >

上海市眼病防治中心 药剂科, 上海 201103

上海交通大学医学院附属第一人民医院 临床药学科,上海 200080

阿柏西普眼内注射溶液 FDA不良事件报告系统数据库 药品不良事件 不良反应信号 数据挖掘

上海市眼病防治中心院内培育项目

2021JC005

2024

临床药物治疗杂志
北京药学会

临床药物治疗杂志

CSTPCD
影响因子:1.07
ISSN:1672-3384
年,卷(期):2024.22(1)
  • 17